Yes nothing like facing death to focus the brain.
It does sound too good to be true.
GK history is easily researched and I believe what hes saying.
Even on his bio section on the NOX website it says "In early-2012, Graham addressed the matter of the transport of isoflavones in the blood of humans, conducting formulation studies in a private capacity that led shortly thereafter to the concept behind NOX66"
He's addressed the issue after working with the drug for years and had a light bulb moment in order to save himself.
Anyhow I know what they say about something being too good to be true.
Early stage nrt or you could argue nrt itself is proof of his ability in many areas.
GK interview with Ross Greenwood, page-2
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.06M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 11.5¢ | $5.653K | 48.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22101 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 159073 | 5 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |